Écrit par InVS | 20 Août 2014

Comme chaque année, l’Institut de veille sanitaire (InVS) poursuit son engagement au service de la santé de tous sur l’ensemble du territoire. L’année 2013 a particulièrement été dense pour l’Institut, tant au niveau des alertes sanitaires, qu’en matière de production d’indicateurs de surveillance, de modernisation de ses systèmes de surveillance et d’évolution...

Écrit par Oxygen Biotherapeutics | 20 Août 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced a collaboration with Imperial College London to provide supplemental funding to support the accelerated enrollment and completion of the ongoing LeoPARDS Trial (Levosimendan...

Écrit par WILEY | 20 Août 2014

A new analysis confirms that U.S. lung cancer rates are declining overall, but it also uncovers previously unrecognized trends related to cancer subtype, sex, race/ethnicity, and age. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings provide a more accurate picture of the state of lung cancer in the country and will help researchers in...

Écrit par WILEY | 20 Août 2014

A new study reveals that one in six patients with systemic lupus erythematosus (SLE) is readmitted to the hospital within 30 days of being discharged. Results published in Arthritis & Rheumatology, a journal of the American College of Rheumatology (ACR), show that black and Hispanic SLE patients were more likely to be readmitted than white patients. Readmissions among patients insured by...